Re:Goldman Sachs questions whether curing patients is a sust...
by croon on Friday April 13, 2018 @10:03AM
(#16830056)
No, there's an incentive for another company to make a treatment and only make $9B(/y).
[ Parent
| on HN ]
There are no comments on this comment yet.